Home » News
Home » News

Remedy Informatics gets growth capital investment

Published November 13, 2012 7:50 am
This is an archived article that was published on sltrib.com in 2012, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

Remedy Informatics Inc., a Salt Lake City-based company that provides software used in medical research, said it has received a $6 million capital investment from the Merck Global Health Innovation Fund.

The investment will give Merck a seat on Remedy's board of director and paves the way for possible additional investments in the future, Gary Kennedy, Remedy's founder and CEO, said in a statement announcing the investment.

He said over the past year the company has experienced unprecedented demand for its research management systems. "This additional capital will fuel our growth here in the U.S. and our expansion into Europe and Latin America," he said.

In addition, Kennedy said the additional capital will allow Remedy to continue to invest in and develop its products so it can bolster its presence in the marketplace.




Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
comments powered by Disqus